Pregenen
Pregenen designs and engineers molecules critical to a new generation of cell-based therapies for unmet medical needs.
Launch date
Employees
Market cap
-
Enterprise valuation
$140m (Public information from Jul 2014)
Seattle Washington (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$140m Valuation: $140m | Acquisition | ||
| Total Funding | - | ||